BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almeida-Paes R, de Andrade IB, Ramos MLM, Rodrigues MVA, do Nascimento VA, Bernardes-Engemann AR, Frases S. Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi. Mem Inst Oswaldo Cruz 2021;116:e210207. [PMID: 34755820 DOI: 10.1590/0074-02760210207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Coelho RA, Alves GM, Figueiredo-Carvalho MHG, Almeida-Silva F, de Souza GR, Lourenço MCDS, Brito-Santos F, Amaral ACF, Almeida-Paes R. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole. Mem Inst Oswaldo Cruz 2022;117:e220089. [PMID: 36102413 DOI: 10.1590/0074-02760220089] [Reference Citation Analysis]
2 Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022. [PMID: 35787715 DOI: 10.1080/17460441.2022.2097659] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lim W, Verbon A, van de Sande W. Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach. Expert Opin Drug Discov 2022. [PMID: 35612364 DOI: 10.1080/17460441.2022.2080195] [Reference Citation Analysis]